#EndoPredict
LightNews LightNews
onco404.bsky.social
A 10-gene signature can now predict recurrence risk for HR+/HER2- early breast cancer #EBC patients post-chemo-endocrine therapy.

@myesmo.bsky.social @breastcancerorg.bsky.social

#Onco404 #Cancer #Kanser #BreastCancer #MemeKanseri #OncotypeDX #MammaPrint #EndoPredict #Prosigna #PAM50 #GGI #MedSky
May 14, 2025 at 7:21 PM
360dx.bsky.social
www.360dx.com/cancer/eu-un...
EU Unified Patent Court Rules in Favor of Myriad Genetics in Breast Cancer IP Dispute
The court invalidated a patent owned by South Korean firm GXD-Bio and rejected the firm's claims that Myriad's EndoPredict breast cancer test infringed on its intellectual property.
www.360dx.com
December 23, 2025 at 6:38 PM
helixbrief.bsky.social
The co-primary endpoints were preoperative endocrine prognostic index (PEPI) score and EndoPredict (EPclin) risk score.
September 21, 2025 at 5:05 AM